Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if continuous subcutaneous delivery of interferon
alfa-2b using an external drug pump in combination with the use of oral ribavirin provides a
safe and effective treatment for patients with chronic hepatitis C infection as compared to
patients who receive standard treatment.